| | Cytochrome P-450 Inhibitors and Inducers
- 1-Aminobenzotriazole
A suicide substrate for cytochrome P-450 and chloroperoxidase, shown to inhibit oxidative drug metabolism in vivo and block ω-oxidation of arachidonic acid but not epoxidation.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200600 | 1614-12-6 | C6H6N4 | 20 mg/100 mg |
- (±)11(12)-EET
Biosynthesized in rat and rabbit liver microsomes by CYP450. Has been shown, along with (±)8(9)-EET, to play a role in the recovery of depleted Ca2+ pools in cultured smooth muscle cells.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-220579 | 81276-02-0 | C20H32O3 | 25 µg/50 µg |
- (±)14(15)-EET
Biosynthesized in rat and rabbit liver microsomes by CYP450.1,2 Dramatic increases in urinary (±)14,15-DiHETrE, which is a (±)14(15)-EET metabolite, have been documented by GC/MS in pregnancy induced hypertension.3| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-220610 | n.n. | C20H32O3 | 25 µg/50 µg |
- (±)14(15)-EET Ethanolamide
An endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. Fatty acid amide hydrolase (FAAH) is the enzyme responsible for the hydrolysis and inactivation of AEA. Metabolism of AEA by cyclooxygenase-2, leading to formation of prostaglandin ethanolamides and by lipoxygenases has also been documented. (±)14(15)-EET ethanolamide is a potential cytochrome P450 (CYP450) metabolite of AEA, although specific stereochemistry rather than a racemic mixture would likely ensue from enzymatic metabolism. CYP450 metabolism of AEA may be particularly relevant under conditions of FAAH inhibition. Evidence for the formation of (±)14(15)-EET ethanolamide in vivo has not been documented.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-220611 | n.n. | C22H37NO3 | 25 µg/50 µg |
- 16(17)-EpDPE
An unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as 14(15)-EpETrE which are prime candidates for the actual active mediator. However, the CYP450 metabolites of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been little studied relative to arachidonate epoxygenase metabolites. Is the DHA homolog of 14(15)-EpETrE, derived via epoxidation of the 16,17-double bond of docosahexaenoic acid (DHA). The EDHF activity of 16(17)-EpDPE has not yet been determined and the epoxygenase metabolites of DHA have also been detected in a murine inflammation model.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-220642 | n.n. | C22H32O3 | 25 µg/50 µg |
- 2,3-dihydrothieno-Thiadiazole Carboxylate
1,2,3-Thiadiazoles are used in agriculture and medicine applications, such as bactericides, fungicides, and antiviral agents. 2,3-dihydrothieno-Thiadiazole carboxylate (MTCC), 100 µM, inactivates and inhibits certain microsomal CYP450 enzymes (CYP2E1 and CYP2B4), but not others (CYP1A2), with inactivation occurring in a mechanism-based manner.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-220770 | n.n. | C6H4N2O2S2 | 50 mg/100 mg |
- 4,5-diphenyl-1,2,3-Thiadiazole
Has diverse applications in medicine and agriculture, including as bactericides, fungicides, and antiviral agents. At 100 μM, an inhibitor of some CYP450 enzymes (CYP2B4, CYP1A2), but not others (CYP2E1), with inhibition occurring in a mechanism-based manner.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205127 | 5393-99-7 | C14H10N2S | 250 mg/500 mg |
- 6',7'-dihydroxy Bergamottin
A potent inhibitor of CYP3A4; appears to be the primary compound in grapefruit juice that is responsible for inhibition of testosterone 6β-hydrolase activity.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205162 | 145414-76-2 | C21H24O6 | 1 mg/10 mg |
- 7-Ethoxyresorufin
Fluorimetric substrate and suicide inhibitor for cytochrome P450, nitric oxide synthesis inhibitor, NADPH-P450 inhibitor, with demonstrated inhibition of vasorelaxant responses to acetylcholine. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200606 | 5725-91-7 | C14H11NO3 | 2 mg/10 mg |
- Benzylimidazole
Found to induce various cytochrome P-450 isozymes and to inhibit thromboxane A2 synthase.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200530 | 4238-71-5 | C10H10N2 | 1 g/5 g |
- β-Naphthoflavone
Cytochrome P450 enzyme system inducer. Protects chemical-induced carcinogenesis by enhancing the detoxification of carcinogens.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205597 | 6051-87-2 | C19H12O2 | 1 g/5 g |
- Clofibrate
A ligand agonist for peroxisome proliferator-activated receptor α (PPARα) and influences expression of cytochromes P450IVA1 and IVA3 in studies with rat liver.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200721 | 637-07-0 | C12H15ClO3 | 1 g |
- Feprazone
A non-steroidal, anti-inflammatory compound reported to induce the cytochrome P-450 II B family of cytochromes.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-279162 | 30748-29-9 | C20H20N2O2 | 200 mg |
- Furafylline
A methyl xanthine derivative with an expanded duration of action than theophylline and it is an inhibitor of cytochrome P4501A2. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-215061 | 80288-49-9 | C12H12N4O3 | 5 mg |
- HET-0016
A potent and selective inhibitor of the biosynthesis of 20-HETE in human renal microsomes with an IC50 of 8.9 nM, selectively inhibiting CYP4A and 4F isoforms.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200673 | 339068-25-6 | C12H18N2O | 5 mg/25 mg |
- Ketoconazole
An inhibitor of thromboxane synthetase and 5-lipoxygenase. Suppresses 5-lipoxygenase-mediated production of leukotrienes. Reduces production of thromboxane A2. Inhibits adrenocorticoid biosynthesis.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200496 | 65277-42-1 | C26H28Cl2N4O4 | 50 mg/500 mg |
- Methoxsalen (8-Methoxypsoralen)
A potent tricyclic fumocoumarin suicide inhibitor of cytochrome P-450.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200505 | 298-81-7 | C12H8O4 | 1 g |
- Metyrapone
Inhibits the biosynthesis of corticosteroid. Reported to rapidly oxidize endogenous NADPH, improve oxidation of cortisol, and inhibit the reduction of cortisone.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200597 | 54-36-4 | C14H14N2O | 200 mg |
- MS-PPOH
A selective inhibitor of the epoxygenation reactions catalyzed by specific CYP450 isozymes.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205392 | 206052-02-0 | C16H21NO4S | 1 mg/5 mg |
- Muscone
Has been shown to induce CYP4F3 and contain antiinflammatory effects by reducing proinflammatory cytokines. Also reported to be weakly estrogenically active in vitro.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200528 | 541-91-3 | C16H30O | 100 mg/500 mg |
- Naringenin-4'-O-beta-D-Glucuronide
Naringenin is a flavanone. Naringenin-4'-O-β-D-Glucuronide is the metabolite of the flavonoid naringin, which has been shown to have an inhibitory effect on the human cytochrome P450 isoform CYP1A2.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-295905 | 158196-35-1 | C21H20O11 | 100 µg/500 µg |
- Rutaecarpine
An alkaloid isolated from the chinese herb Evodia rutaecarpa which has vasorelaxing effect andinhibits platelet aggregation and COX-2. This compound is a selective inhibitor of cytochrome P450 1A.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205846 | 84-26-4 | C18H13N3O | 10 mg/25 mg |
- SKF-525A HCl (Proadifen)
Exhibits a wide array of activity, including: inhibition of NOS1, AChR, CYP4, transmembrane Ca2+ influx, and platelet thromboxane synthesis, as well as blockage of KIR6.1, and stimulation of endothelial cell prostacyclin production.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200492 | 62-68-0 | C23H32ClNO2 | 250 mg/1 g |
- YM 511
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-361413 | 148869-05-0 | C16H12BrN5 | 10 mg/50 mg |
|